Design and validation of an adherence scale to oral antineoplastic drugs

被引:0
|
作者
Talens-Bolos, Amparo [1 ,2 ]
Lopez-Pintor, Elsa [2 ,3 ]
Guilabert-Mora, Mercedes [4 ]
Aznar-Saliente, Teresa [2 ,5 ]
Orozco-Beltran, Domingo L. [6 ]
Lumbreras-Lacarra, Blanca [3 ,7 ]
机构
[1] Hosp Gen Univ Elda, Serv Farm, Alicante, Spain
[2] Univ Miguel Hernandez, Dept Ingeniena, Area Farm & Tecnologfa Farmaceut, Alicante, Spain
[3] Ctr Invest Biomed Red Epidemiologfa & Salud Publ C, Madrid, Spain
[4] Univ Miguel Hernandez, Dept Psicologfa Salud, Alicante, Spain
[5] Hosp Gen Univ San Juan Alicante, Serv Farm, Alicante, Spain
[6] Univ Miguel Hernandez, Dept Med Clfn, Alicante, Spain
[7] Univ Miguel Hernandez, Dept Salud Publ Hist Ciencia, Alicante, Spain
关键词
Adherence; Oral chemotherapy; Validation; Questionnaire;
D O I
10.1016/j.farma.2022.11.005
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objective: To design and validate a questionnaire to measure adherence to oral antineoplastic drugs. The availability of a simple, validated tool that can be applied to routine care will make it possible to detect and identify non-adherence in order to establish strategies to improve adherence and optimize the quality of healthcare services.Method: Validation study of the questionnaire designed to assess adherence to antineoplastic drugs in a sample of outpatients who collect their medication in two Spanish hospitals. Its validity and reliability will be analyzed, based on a previous qualitative methodology study, using classical test theory and Rasch analysis. We will examine its per-formance, item fit, response structure and person fit to the predictions of the model, as well as dimensionality, item-person reliability, the appropriateness of the level of difficulty of the items to the sample, and the differential perfor-mance of the items according to gender. (c) 2022 The Authors. Published by Elsevier Espaila, S.E.F.H.
引用
收藏
页码:80 / 84
页数:5
相关论文
共 50 条
  • [1] [Translated article] Design and validation of a scale to measure adherence to oral antineoplastic drugs
    Talens-Bolos, Amparo
    Lopez-Pintor, Elsa
    Guilabert-Mora, Mercedes
    Aznar-Saliente, Teresa
    Orozco-Beltran, Domingo L.
    Lumbreras-Lacarra, Blanca
    FARMACIA HOSPITALARIA, 2023, 47 (02) : T80 - T84
  • [2] A review of factors influencing non-adherence to oral antineoplastic drugs
    Xiomara Skrabal Ross
    Kate M. Gunn
    Vijayaprakash Suppiah
    Pandora Patterson
    Ian Olver
    Supportive Care in Cancer, 2020, 28 : 4043 - 4050
  • [3] A review of factors influencing non-adherence to oral antineoplastic drugs
    Ross, Xiomara Skrabal
    Gunn, Kate M.
    Suppiah, Vijayaprakash
    Patterson, Pandora
    Olver, Ian
    SUPPORTIVE CARE IN CANCER, 2020, 28 (09) : 4043 - 4050
  • [4] Adherence to therapy with oral antineoplastic agents
    Partridge, AH
    Avorn, J
    Wang, PS
    Winer, EP
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2002, 94 (09): : 652 - 661
  • [5] A Systematic Review of Adherence to Oral Antineoplastic Therapies
    Greer, Joseph A.
    Amoyal, Nicole
    Nisotel, Lauren
    Fishbein, Joel N.
    MacDonald, James
    Stagl, Jamie
    Lennes, Inga
    Temel, Jennifer S.
    Safren, Steven A.
    Pirl, William F.
    ONCOLOGIST, 2016, 21 (03): : 354 - 376
  • [6] [Translated article] Adherence and quality of life in patients with chronic lymphocytic leukemia treated with oral antineoplastic drugs
    Sufrategui, Maria Ochagavia
    Lemus, Maria Angeles Gil
    Segundo, Lucrecia Yanez San
    Diago, Carlos Antonio Amado
    Villanueva, Sara Barbadillo
    Callejo, Virginia Martinez
    Palomares, Maria Victoria Villacanas
    Dominguez, Marta Valero
    FARMACIA HOSPITALARIA, 2023, 47 (02) : T69 - T74
  • [7] Recycling Discarded Drugs: Improving Access to Oral Antineoplastic Drugs
    Layton, Jodi L.
    Lewis, Brian
    Ryan, Charles
    Beer, Tomasz M.
    Sartor, Oliver
    ONCOLOGIST, 2019, 24 (03): : 291 - 292
  • [8] Re: Adherence to therapy with oral antineoplastic agents - Response
    Partridge, AH
    Avorn, J
    Wang, PS
    Winer, EP
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2002, 94 (21): : 1652 - 1652
  • [10] Therapeutic drug monitoring of oral targeted antineoplastic drugs
    Anna Mueller-Schoell
    Stefanie L. Groenland
    Oliver Scherf-Clavel
    Madelé van Dyk
    Wilhelm Huisinga
    Robin Michelet
    Ulrich Jaehde
    Neeltje Steeghs
    Alwin D.R. Huitema
    Charlotte Kloft
    European Journal of Clinical Pharmacology, 2021, 77 : 441 - 464